UnitedHealth (UNH) Current Situation
Guidance reaffirmed: Management reiterated ≥ $16.00 EPS and $445.5B–$448B revenue for FY2025. This is broadly in line with Wall Street’s expectations, signalling stability.
Market reaction: Shares broke through the $320 resistance level, which had been a ceiling for months. Technical traders view this as a bullish breakout.
Valuation context: At ~$320, UNH trades around 20x forward earnings—not cheap, but reasonable for a defensive healthcare leader with consistent growth.
---
Short-Term View
Breakout risk: After a strong run, stocks often pause or consolidate as early buyers take profits.
Catalysts ahead: Medicare Advantage enrolments, medical cost trends, and regulatory headlines can drive near-term swings.
Technical momentum: As long as UNH holds above ~$320, momentum traders will likely keep buying dips. If it falls back below that level, a near-term top could be in place.
---
Long-Term View
Business moat: UNH is the largest U.S. health insurer, with strong diversification (Optum health services, pharmacy benefit management, data analytics).
Secular drivers: Aging U.S. population, demand for cost-efficient care, and increasing penetration of value-based healthcare support steady growth.
Buffett angle: Berkshire Hathaway holds significant healthcare exposure (though more in pharma and insurance broadly). UNH is often mentioned as a Buffett-style stock—scale, predictable earnings, strong cash flow—even if Berkshire hasn’t disclosed a direct stake.
---
✅ Verdict
Short term: UNH may be approaching a local peak after the breakout—some profit-taking is likely.
Long term: The reaffirmed guidance, defensive nature, and secular tailwinds argue for continued strength. If you are a long-term investor, dips toward support levels (~$310–$315) could be attractive entries rather than exits.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.
